Fibrolase, an active thrombolytic enzyme in arterial and venous thrombosis model systems

Advances in Experimental Medicine and Biology

Volumn 391, Issue , 1996, Pages 427-438

  Markland, F S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; FIBROLASE; PLASMINOGEN ACTIVATOR; SNAKE VENOM; STREPTOKINASE; UROKINASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME PURIFICATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RENAL ARTERY THROMBOSIS; THROMBOSIS; VEIN THROMBOSIS;

EID: 0029950898     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0361-9_36     Document Type: Article

References (32)

1. Abel, H., 1992, Thrombolysis: the logical approach for the treatment of vascular occlusions, Acta Cardiology 47:287-295.
2. Lijnen, H.R. and Collen, D., 1991, Strategies for the improvement of thrombolytic agents. Thrombos. Haemostas, 66:88-110.
3. Collen, D, 1990, Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator. Ann. Intern. Med. 112:529-538.
4. Lawrence, P.F. and Goodman, G.R., 1992, Thrombolytic therapy, Surg. Clin. North Am. 72:899-918.
5. Rapaport, E., 1991, Thrombolysis, anticoagulation, and reocclusion, Am. J. Cardiol. 68:17E-22E.
6. Caramelli, P., Mutarelli, F.G., Caramelli, B., Tranchesi, B., Pileggi, F. and Scaff, M., 1992, Neurological complications after thrombolytic treatment for anti myocardial infarction: emphasis on unprecedented manifestations, Acta Neurologica Scand. 85:331-333.
7. Maggioni, A.P., Franzosi, M.G., Santoro, F., White, H., Vandewerf, F. andTognoni, G., 1992, The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. New Engl. J. Med. 327:1-6.
8. Kase, C.S., Pessin, M.S., Zivin, J.A., delZoppo, G.J., Furlan, A.J., Buckley, J.W., Snipes, R.G. and LittleJohn, J.K., 1992, Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator, Am. J. Med. 92:384-390.
9. Kruithof, E.K.O., 1988, Inhibitors of plasminogen activators. In: Tissue-Type Plasminogen Activator (t-PA): Physiological and Clinical Aspects (C. Kluft, Ed.), CRC Press, Inc., Boca Raton, pp 189-210.
10. Gram, J., Kluft, C. and Jespersen, J., 1987, Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infaction (AMI), Thrombos. Haemostas. 58: 817-821.
11. Vaughan, D.E., Declerck, P.J., Van Houtte, E., DeMol, M. and Collen, D., 1992, Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivo, Thrombos. Haemostas. 68:60-63.
12. Collen, D., 1994, Development of new fibrinolytic agents, In: Haemostasis and Thrombosis (A.L. Bloom, C.D. Forbes, D.P. Thomas and E.G.D. Tuddenham, Eds.), 3rd Ed., Churchill Livingstone, New York, pp 625-637.
13. Markland, F.S., 1988, Fibrinogenolytic enzymes from snake venoms, In: Hemostasis and Animal Venoms (H. Pirkle and F.S. Markland, Eds.), Marcel Dekker, Inc., New York, pp. 149-172.
14. Guan, A.L., Retzios, A.D., Henderson, G.N. and Markland, F.S., 1991, Purification and characterization of a fibrinolytic enzyme from venom of the southern copperhead snake (Agkistrodon contortrix contortrix), Arch. Biochem. Biophys. 289:197-207.
15. Randolf, A., Chamberlain, S.H., Chu, C., Retzios, A.D., Markland, F.S. and Masiarz, F.R., 1992, Amino acid sequence of fibrolase, a direct-acting fibrinolytic enzyme from Agkistrodon contortrix contortrix venom, Protein Science 1:590-600.
16. Bode, W., Gomis-Ruth, F-X. and Stockler, W., 1993, Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins', FEBS Letters 331:134-140.
17. Gomis-Ruth, F-X., Kress, L.F. and Bode, W., 1993, First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases, EMBO J. 12:4151-4157.
18. 0 x-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin, J. Mol. Biol. 239:513-544.
19. Retzios, A.D. & Markland, F.S., 1988, A direct-acting fibrinolytic enzyme from the venom of Agkistrodon contortrix contortrix: Effcts on various components of the human blood coagulation and fibrinolytic systems, Thrombos. Res. 52:541-552.
20. Ahmed, N.K., Tennant, K.D., Markland, F.S. and Lacz, J.P., 1990, Biochemical characteristics of fibrolase, a fibrinolytic protease from snake venom, Haemostas. 20:147-154.
21. Esmon, C.T., 1983, Protein C: biochemistry, physiology and clinical implication, Blood 62:1155-1158.
22. Markland, F.S., Friedrichs, G.S., Pewitt, S.R. and Lucchesi, B.R., 1994, Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis. Circulation 90:2448-2456.
23. Markland, F.S., Bookstein, J.J., and Machado, T., 1989, In vivo fibrinolytic activity of fibrolase, a metalloproteinase from the venom of Agkistrodon contortrix contortrix, Thrombos. Haemostas. 62:121.
24. Loayza, S.L.,Trikha, M., Markland, F.S., Riquelme, P. and Kuo, J., 1994, Resolution of isoforms of natural and recombinant fibrolase, the fibrinolytic enzyme from Agkistrodon contortrix contortrix snake venom, and comparison of their EDTA sensitivities, J Chromatog. B 662:227-243.
25. Retzios, A.D., and Markland, F.S., 1990, HPLC-based two-step purification of fibrinolytic enzymes from the venoms of Agkistrodon contortrix contortrix and Agkistrodon piscivorus conantii, Prot. Express. Purific. 1.33-39.
26. Markland, F.S. and Guan, A.L., 1986, The Use of IPG to purify a fibrinolytic snake venom enzyme, Protides of the Biological Fluids 34:807-810.
27. Markland, F.S., Morris, S., Deschamps, J.R. and Ward, K.B., 1993, Resolution of isoforms of natural and recombinant fibrinolytic snake venom enzyme using high performance capillary electrophoresis. J. Liquid Chromatog. 16:2189-2201.
28. Trikha, M., Schmitmeier, S. and Markland, F.S., 1994, Purification and characterization of fibrolase isoforms from venom of individual southern copperhead (Agkistrodon contortrix contortrix) snakes, Toxicon 32:1521-1531.
29. Coller, B.S., 1985, A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of platelet GPIIb/IIIa complex, J. Clin. Invest. 76:101-108.
30. Romson, J.L., Haack, D.W. and Lucchesi, B.R., 1980, Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents. Thromb. Res. 17:841-853.
31. Rote, W.E., Mu, D-X. and Lucchesi, B.R., 1993, Thromboxane antagonism in experimental canine carotid artery thrombosis. Stroke 24:820-828.
32. Ahmed, N.K., Gaddis, R.R., Tennant, K.D. and Lacz, J.P., 1990, Biological and thrombolytic properties of fibrolase: a new fibrinolytic prolease from snake venom. Haemostas. 20:334-340.